Anti-Human CD115 Recombinant Antibody(Cabiralizumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CD115 Recombinant Antibody(Cabiralizumab)

Anti-Human CD115 Recombinant Antibody(Cabiralizumab)

产品编号

YR1397

别名

科研级 Cabiralizumab ( 卡比利珠单抗 ), Anti-CD115 Recombinant Antibody, Research Grade Cabiralizumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Cabiralizumab ( 卡比利珠单抗 ), Anti-CD115 Recombinant Antibody, Research Grade Cabiralizumab
Catalog Number	YR1397
Molecular Name	Cabiralizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4 Kappa
Formulation	PBS, pH7.5
Background	CSF1R inhibitionitors have been developed as a potential route to reduce the presence of TAMs in the tumor microenvironment. As of 2017, CSF1R inhibitionitors that are currently in early stage clinical trials include Pexidartinib, PLX7486, ARRY-382, JNJ-40346527, BLZ945, Emactuzumab, AMG820, IMC-CS4, MCS110, and Cabiralizumab.
CAS Number	1613144-80-1
Application	ELISA, IHC, IF, IP, FCM, Inhib
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD115[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0